Donald Trump nominates man whose firm tripled price of insulin to regulate drug companies | The Independent

Donald Trump nominates man whose firm tripled price of insulin to regulate drug companies | The Independent

Donald Trump’s pick for health secretary, Alex Azar, was previously an executive at a pharmaceutical company that repeatedly raised the prices of its drugs and tripled the cost of its top-selling insulin over the five years he served as a company president, it has emerged.

Mr Trump announced his choice on Monday, tweeting that Mr Azar would be a “star for better healthcare and lower drug prices”.

If Mr Azar becomes Health and Human Services (HHS) secretary, he will oversee a $1tr (£76bn) department responsible for America’s major insurance programmes, including Obamacare, public health, medical research and food and drug safety.

via Donald Trump nominates man whose firm tripled price of insulin to regulate drug companies | The Independent

Stealing them blind, out in open sight.